S INCE THE INITIAL description of the Ki-l monoclonal antibody (MoAb) in 1982,'there has
been an overwhelming flood of information concerning the Hodgkm's disease@)-associated …

Abstract The CD30 ligand (CD30L) is a type II transmembrane glycoprotein of the tumor
necrosis factor ligand superfamily. Recent cloning of CD30L has enabled studies to explore …

In 1982 Stein and coworkers identified a new molecule, CD30 (Ki-1), which is expressed by
Reed–Sternberg (RS) cells of Hodgkin's Disease (HD)(1). Although CD30 is not a specific …

CD30 is a member of the tumor necrosis factor receptor superfamily. CD30 was originally
described as a cell surface antigen on primary and cultured Hodgkin's and Reed-Sternberg …

The recently identified CD27 ligand (L) Is a type II transmembrane molecule with significant
structural homology to tumor necrosis factor (TNF)-α, TNF-β, lymphotoxin β, CO40L, and …

CD30 is a surface marker for neoplastic cells of Hodgkin's lymphoma and shows sequence
homology to members of the tumor necrosis factor (TNF) receptor superfamily. Using a …

CD27 is a surface antigen found on T and B ceils that has homology to a family of molecules
including the receptors for tumor necrosis factor (TNF) and nerve growth factor. A cDNA …

CD30 is a member of the tumor necrosis factor receptor superfamily. It is characteristically
expressed in certain hematopoietic malignancies, including anaplastic large cell lymphoma …

Abstract CD30 ligand (CD30L) is a type-II membrane glycoprotein capable of transducing
signals leading to either cell death or proliferation through its specific counterstructure …

Originally, expression of the CD30 antigen was shown to be typical of the tumour cells of
Hodgkin's disease (HD) and of anaplastic large cell lymphomas (ALCLs). In reactive …